Cesar Ivan Elizalde-Barrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cesar Ivan Elizalde-Barrera has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Alberto Francisco Rubio-Guerra
Hospital General de Ticoman, Servicios de Salud Publica de la Ciudad de Mexico, Plan de San Luis S/N, Col. Ticoman, Alcaldía Gustavo A. Madero, C.P. 07330 Ciudad de México, Mexico
2 shared publications- Alberto Francisco Rubio-Guerra
Metabolic and Research Clinic, Hospital General de Ticomán SS DF, México DF, Mexico
2 shared publications - Alberto Francisco Rubio-Guerra
Echocardiography Department, Hospital General de Ticomán, CDMX 07330, Mexico
2 shared publications Ana K. Garro-Almendaro
Hospital General de Ticomán SS DF, Mexican Group for Basic and Clinical Research, México
2 shared publicationsAndrea Maliachi-Díaz
Servicio de Oncología Médica Instituto Nacional de Cancerología
2 shared publicationsCarlos V. Juárez-Mendoza
Servicio de Medicina Interna Hospital General de Zona Numero 30 Instituto Mexicano del Seguro Social (IMSS)
2 shared publications
Latest Publications
- 24 November 2026
- Published by Ediciones Prado
- Vol. 2 (1) , 11-16
Correlación entre el índice aterogénico del plasma y el péptido natriurético tipo B en pacientes con insuficiencia cardíaca cronica agudizada
Objetivo: Determinar la correlación entre el Índice Aterogénico del Plasma (IAP) y el Péptido Natriurético tipo B (BNP) en pacientes con Insuficiencia Cardíaca Crónica Agudizada. Material y métodos: Estudio transversal, correlacional, analítico. A través de un muestreo no probabilístico, fueron evaluados pacientes con insuficiencia cardíaca crónica agudizada, con medición al ingreso de BNP, perfil de lípidos y a quienes fue realizado un ecocardiograma transtorácico durante su hospitalización. Resultados: Fueron estudiados 30 pacientes con insuficiencia cardíaca agudizada. La mediana de los niveles de BNP al ingreso fue de 764.5 pg/mL, la mediana del IAP fue de 0.51. La media de la fracción de eyección del ventrículo izquierdo (FEVI) obtenida fue de 38%, todos los pacientes presentaron algún grado de disfunción diastólica: el 50% grado 1, el 33.3% grado 2 y sólo el 16.6% grado 3. El coeficiente de correlación de Spearman para el BNP e IAP fue de -0,02213, con un valor de p=0.5. Conclusiones: El IAP juega un papel como un factor de riesgo cardiovascular, pero no como parte de la evaluación de los pacientes con Insuficiencia Cardíaca Crónica Agudizada. No existe correlación entre el IAP y BNP.
- 24 November 2026
- Published by Ediciones Prado
- Vol. 2 (1) , 11-16
Correlación entre el índice aterogénico del plasma y el péptido natriurético tipo B en pacientes con insuficiencia cardíaca cronica agudizada
Objetivo: Determinar la correlación entre el Índice Aterogénico del Plasma (IAP) y el Péptido Natriurético tipo B (BNP) en pacientes con Insuficiencia Cardíaca Crónica Agudizada. Material y métodos: Estudio transversal, correlacional, analítico. A través de un muestreo no probabilístico, fueron evaluados pacientes con insuficiencia cardíaca crónica agudizada, con medición al ingreso de BNP, perfil de lípidos y a quienes fue realizado un ecocardiograma transtorácico durante su hospitalización. Resultados: Fueron estudiados 30 pacientes con insuficiencia cardíaca agudizada. La mediana de los niveles de BNP al ingreso fue de 764.5 pg/mL, la mediana del IAP fue de 0.51. La media de la fracción de eyección del ventrículo izquierdo (FEVI) obtenida fue de 38%, todos los pacientes presentaron algún grado de disfunción diastólica: el 50% grado 1, el 33.3% grado 2 y sólo el 16.6% grado 3. El coeficiente de correlación de Spearman para el BNP e IAP fue de -0,02213, con un valor de p=0.5. Conclusiones: El IAP juega un papel como un factor de riesgo cardiovascular, pero no como parte de la evaluación de los pacientes con Insuficiencia Cardíaca Crónica Agudizada. No existe correlación entre el IAP y BNP.
- Open Access
- 27 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e79775
Determining Insulin Resistance Cutoffs in Mexican Adults: Percentile Distribution vs. Receiver Operating Characteristic Curve Analysis
Introduction Insulin resistance (IR) plays a key role in the development of metabolic syndrome (MetS), type 2 diabetes, and cardiovascular disease. The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) is widely used to estimate IR, but there is no consensus on the optimal cutoff values for identifying individuals at risk. This study aims to compare two methodologies, percentile distributions and receiver operating characteristic (ROC) curve analysis, for determining optimal HOMA-IR cutoff values in a population from Mexico City. Methods This cross-sectional study included 765 adults recruited from a hospital outpatient clinic in Mexico City. Participants were divided into two groups: a reference group of individuals with healthy weight and fasting plasma glucose and a MetS group of overweight or obese individuals classified based on the presence or absence of MetS. HOMA-IR values were analyzed using the 75th percentile in the reference group and ROC curve analysis in the MetS group. Optimal cutoffs were determined using the Youden index. Results We include a total of 765 patients, 218 subjects in the reference group and 547 for the ROC curve analysis. HOMA-IR percentiles 75th and 90th were 2.72 and 3.71, respectively. ROC curve analysis yielded higher cutoff values for MetS diagnosis than the percentile-based method. The percentile-based approach allowed for earlier identification of individuals at risk, including those without clinical manifestations of MetS. Conclusions This study highlights the variability in HOMA-IR cutoff values across methodologies and emphasizes the importance of population-specific reference values. A percentile-based approach proves effective for early detection of IR, facilitating preventive interventions during the preclinical stage. These findings support using percentile-based cutoffs as a practical tool for improving risk assessment and guiding clinical decision-making.
- 27 February 2025
- Published by Springer Nature in Cureus
- Vol. 17 (2) , e79775
Open AccessDetermining Insulin Resistance Cutoffs in Mexican Adults: Percentile Distribution vs. Receiver Operating Characteristic Curve Analysis
Introduction Insulin resistance (IR) plays a key role in the development of metabolic syndrome (MetS), type 2 diabetes, and cardiovascular disease. The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) is widely used to estimate IR, but there is no consensus on the optimal cutoff values for identifying individuals at risk. This study aims to compare two methodologies, percentile distributions and receiver operating characteristic (ROC) curve analysis, for determining optimal HOMA-IR cutoff values in a population from Mexico City. Methods This cross-sectional study included 765 adults recruited from a hospital outpatient clinic in Mexico City. Participants were divided into two groups: a reference group of individuals with healthy weight and fasting plasma glucose and a MetS group of overweight or obese individuals classified based on the presence or absence of MetS. HOMA-IR values were analyzed using the 75th percentile in the reference group and ROC curve analysis in the MetS group. Optimal cutoffs were determined using the Youden index. Results We include a total of 765 patients, 218 subjects in the reference group and 547 for the ROC curve analysis. HOMA-IR percentiles 75th and 90th were 2.72 and 3.71, respectively. ROC curve analysis yielded higher cutoff values for MetS diagnosis than the percentile-based method. The percentile-based approach allowed for earlier identification of individuals at risk, including those without clinical manifestations of MetS. Conclusions This study highlights the variability in HOMA-IR cutoff values across methodologies and emphasizes the importance of population-specific reference values. A percentile-based approach proves effective for early detection of IR, facilitating preventive interventions during the preclinical stage. These findings support using percentile-based cutoffs as a practical tool for improving risk assessment and guiding clinical decision-making.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (14) , 1640-1650
Gender Differences in the Predictive Value of Obesity Indices for Insulin Resistance in Adult Mexican Individuals
Background: Obesity-linked insulin resistance (IR) is an important risk factor for metabolic diseases, and anthropometric indices are commonly used for risk assessment. Aim: The study aimed to assess possible differences between women and men in the predictive value and association of nine obesity indices with IR, as assessed by HOMA-IR, in a nondiabetic adult population. Methods: The cross-sectional study included individuals recruited from a hospital in Mexico City. Indices evaluated were waist circumference (WC), hip circumference (HC), body mass index (BMI), waist-to-hip ratio, waist-to-height ratio, visceral adiposity index, body adiposity index (BAI), relative fat mass (RFM), and conicity index (CI). Fasting plasma glucose and insulin were measured to calculate HOMA-IR. Correlation analysis was performed between obesity indices and HOMA-IR. Receiver operating characteristics curve analyses were performed to determine predictive accuracy and cut-off values of obesity indices for IR. A binary logistic regression (BLR) analysis with OR calculation was performed to determine the strength of association with HOMA-IR. Results: We included 378 individuals (59% females, mean age 46.38 ±12.25 years). The highest Pearson coefficient value was observed for BMI among women, while among men, the highest values were found for BMI and BAI. WC among women, and BAI and RFM among men showed the highest sensitivity, while the highest specificity was observed for WHR among women and WC among men with respect to insulin prediction. In the adjusted BLR model, BMI, WC, and WHR among women and WC and RFM and BAI among men were independently associated with IR, showing the highest odds ratio (OR). Conclusion: In Mexican adults, WC, WHR, RFM and BAI could be complementary tools for BMI in screening for IR.
- 1 November 2024
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 24 (14) , 1640-1650
Gender Differences in the Predictive Value of Obesity Indices for Insulin Resistance in Adult Mexican Individuals
Background: Obesity-linked insulin resistance (IR) is an important risk factor for metabolic diseases, and anthropometric indices are commonly used for risk assessment. Aim: The study aimed to assess possible differences between women and men in the predictive value and association of nine obesity indices with IR, as assessed by HOMA-IR, in a nondiabetic adult population. Methods: The cross-sectional study included individuals recruited from a hospital in Mexico City. Indices evaluated were waist circumference (WC), hip circumference (HC), body mass index (BMI), waist-to-hip ratio, waist-to-height ratio, visceral adiposity index, body adiposity index (BAI), relative fat mass (RFM), and conicity index (CI). Fasting plasma glucose and insulin were measured to calculate HOMA-IR. Correlation analysis was performed between obesity indices and HOMA-IR. Receiver operating characteristics curve analyses were performed to determine predictive accuracy and cut-off values of obesity indices for IR. A binary logistic regression (BLR) analysis with OR calculation was performed to determine the strength of association with HOMA-IR. Results: We included 378 individuals (59% females, mean age 46.38 ±12.25 years). The highest Pearson coefficient value was observed for BMI among women, while among men, the highest values were found for BMI and BAI. WC among women, and BAI and RFM among men showed the highest sensitivity, while the highest specificity was observed for WHR among women and WC among men with respect to insulin prediction. In the adjusted BLR model, BMI, WC, and WHR among women and WC and RFM and BAI among men were independently associated with IR, showing the highest odds ratio (OR). Conclusion: In Mexican adults, WC, WHR, RFM and BAI could be complementary tools for BMI in screening for IR.
- Open Access
- 21 March 2024
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos (English Edition)
- Vol. 91 (1) , 100-106
Prevalence of impaired fasting glucose and dyslipidemia among Mexican HIV antiretroviral-naïve patients
Background: Metabolic complications have become more relevant in the care of patients with HIV. However, little is known about the incidence and risk factors...
- 21 March 2024
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos (English Edition)
- Vol. 91 (1) , 100-106
Open AccessPrevalence of impaired fasting glucose and dyslipidemia among Mexican HIV antiretroviral-naïve patients
Background: Metabolic complications have become more relevant in the care of patients with HIV. However, little is known about the incidence and risk factors...
- Open Access
- 15 March 2024
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos (English Edition)
- Vol. 90 (5) , 659-664
Stroke epidemiology and in-hospital mortality in a Mexico City hospital: a prospective two-years study
Objective: To describe patient characteristics, case fatality rate, and assess predictors of in-hospital acute ischemic (IS) or hemorrhagic stroke (HS) morta...
- 15 March 2024
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos (English Edition)
- Vol. 90 (5) , 659-664
Open AccessStroke epidemiology and in-hospital mortality in a Mexico City hospital: a prospective two-years study
Objective: To describe patient characteristics, case fatality rate, and assess predictors of in-hospital acute ischemic (IS) or hemorrhagic stroke (HS) morta...
- 29 December 2023
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 21 (4) , 248-253
Late Diagnosis at Entry on Care in an HIV Clinic in Mexico City: Possibly COVID-19 Pandemic Impact
Background: HIV late-stage diagnoses have an important impact on mortality. Unfortunately, a significant number of patients are still diagnosed at late stages. On the other hand, the coronavirus disease 2019 (COVID-19) pandemic has created an unprecedented crisis in healthcare systems worldwide, including HIV care services. : The aim of this study was to compare time-trends in HIV late diagnosis, prevalence, and initial CD4 cell counts of newly diagnosed HIV-positive individuals at the entry to HIV care in a General Hospital in Mexico City and to assess the Covid-19 pandemic possible effects on late diagnosis prevalence. Methods: We retrospectively analyzed the data of HIV-infected patients (January 1999 to December 2021) to assess the prevalence of Late presentation (LP, CD4 count < 350 cells/mm3) and presentation with advanced HIV disease (AHIVD CD4 count < 200 cells/mm3). Differences across time were evaluated, focusing on years of the Covid-19 pandemic. Results: We included 348 newly diagnosed HIV-positive individuals, of which 255 (73.2%) patients entered into care with LP, and 158 (45.4%) were on AHIVD. The proportion of patients with LP and AHIVD decreased significantly across the study period. Nevertheless, we found an increase in this proportion in the years 2020 (70% and 53%) and 2021 (86% and 68%). Conclusion: Despite the progressive decrease in late diagnosis prevalence in our population, it remains high. Even more, our results documented a possible increase in the prevalence of late diagnosis associated with the COVID-19 pandemic. These findings highlight the need to prioritize interventions to evaluate and reverse pandemic effects on people living with HIV care.
- 29 December 2023
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 21 (4) , 248-253
Late Diagnosis at Entry on Care in an HIV Clinic in Mexico City: Possibly COVID-19 Pandemic Impact
Background: HIV late-stage diagnoses have an important impact on mortality. Unfortunately, a significant number of patients are still diagnosed at late stages. On the other hand, the coronavirus disease 2019 (COVID-19) pandemic has created an unprecedented crisis in healthcare systems worldwide, including HIV care services. : The aim of this study was to compare time-trends in HIV late diagnosis, prevalence, and initial CD4 cell counts of newly diagnosed HIV-positive individuals at the entry to HIV care in a General Hospital in Mexico City and to assess the Covid-19 pandemic possible effects on late diagnosis prevalence. Methods: We retrospectively analyzed the data of HIV-infected patients (January 1999 to December 2021) to assess the prevalence of Late presentation (LP, CD4 count < 350 cells/mm3) and presentation with advanced HIV disease (AHIVD CD4 count < 200 cells/mm3). Differences across time were evaluated, focusing on years of the Covid-19 pandemic. Results: We included 348 newly diagnosed HIV-positive individuals, of which 255 (73.2%) patients entered into care with LP, and 158 (45.4%) were on AHIVD. The proportion of patients with LP and AHIVD decreased significantly across the study period. Nevertheless, we found an increase in this proportion in the years 2020 (70% and 53%) and 2021 (86% and 68%). Conclusion: Despite the progressive decrease in late diagnosis prevalence in our population, it remains high. Even more, our results documented a possible increase in the prevalence of late diagnosis associated with the COVID-19 pandemic. These findings highlight the need to prioritize interventions to evaluate and reverse pandemic effects on people living with HIV care.
- Open Access
- 22 February 2023
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 91 (1) , 100-106
Prevalencia de glucosa alterada en ayuno y dislipidemia entre pacientes mexicanos con VIH naïve a tratamiento antirretroviral
Metabolic complications have become more relevant in the care of patients with HIV. However, little is known about the incidence and risk factors for these disorders among HIV-infected antiretroviral treatment naïve (ARTn) patients. To recognize the prevalence of Impaired Fasting Glucose (IFG) and dyslipidemia among HIV-infected ARTn Mexican individuals and identify associated risk factors. A retrospective study was conducted in HIV-1-infected ART-N patients, referred for attention to a general hospital in Mexico City, between 2009 and 2019. We collected information for anthropometric, clinical, biochemical and HIV status variables. We included 221 patients, 97% were males, mean age 30 years (interquartile range [IQR]: 25-38); median CD4 count was 250 cells/mm3 (IQR: 120.25-391) and median log10 HIV viral load was 4.69 HIV-1 RNA copies/ml (IQR: 3.64-5.25). Prevalence of IFG was 22.6% and was associated with overweight-obesity (odds ratio [OR]: 2.75; 95% confidence interval [95% CI]: 1.36-5.55; p-value < 0.05). Hypoalphalipoproteinemia was the most frequent dyslipidemia: 69.46%. An association between count CD4 < 250 and lower HDL cholesterol levels was found (OR: 3.23; 95CI%: 1.61-6.5; p-value < 0.05). IFG and dyslipidemia are highly prevalent among HIV-infected ART-naïve Mexican patients, therefore, screening for glucose and lipids abnormalities always should be considered among ARTn patients.
- 22 February 2023
- Published by Instituto Mexicano del Seguro Social in Cirugía y Cirujanos
- Vol. 91 (1) , 100-106
Open AccessPrevalencia de glucosa alterada en ayuno y dislipidemia entre pacientes mexicanos con VIH naïve a tratamiento antirretroviral
Metabolic complications have become more relevant in the care of patients with HIV. However, little is known about the incidence and risk factors for these disorders among HIV-infected antiretroviral treatment naïve (ARTn) patients. To recognize the prevalence of Impaired Fasting Glucose (IFG) and dyslipidemia among HIV-infected ARTn Mexican individuals and identify associated risk factors. A retrospective study was conducted in HIV-1-infected ART-N patients, referred for attention to a general hospital in Mexico City, between 2009 and 2019. We collected information for anthropometric, clinical, biochemical and HIV status variables. We included 221 patients, 97% were males, mean age 30 years (interquartile range [IQR]: 25-38); median CD4 count was 250 cells/mm3 (IQR: 120.25-391) and median log10 HIV viral load was 4.69 HIV-1 RNA copies/ml (IQR: 3.64-5.25). Prevalence of IFG was 22.6% and was associated with overweight-obesity (odds ratio [OR]: 2.75; 95% confidence interval [95% CI]: 1.36-5.55; p-value < 0.05). Hypoalphalipoproteinemia was the most frequent dyslipidemia: 69.46%. An association between count CD4 < 250 and lower HDL cholesterol levels was found (OR: 3.23; 95CI%: 1.61-6.5; p-value < 0.05). IFG and dyslipidemia are highly prevalent among HIV-infected ART-naïve Mexican patients, therefore, screening for glucose and lipids abnormalities always should be considered among ARTn patients.
- Open Access
- 11 October 2017
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 8 (10) , 141-146
Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid
Hyperuricemia leads to insulin resistance, whereas insulin resistance decreases renal excretion of uric acid. The aim of this study was to evaluate whether there is a correlation between serum uric acid levels with homeostatic model assessment (HOMA) 1 in nondiabetic patients. We evaluated 88 nondiabetic patients, in whom uric acid levels were measured, in all of them HOMA of β-cell function (HOMA 1B) and HOMA of insulin resistance (HOMA 1IR) scores were performed. Uric acid and the HOMA 1 values were correlated using the Pearson coefficient. We did not find any correlation between uric acid levels with both HOMA 1B (r = 0.102, p = 0.343), nor with HOMA 1IR (r = 0.158, p = 0.117). When patients were analyzed by sex, we found a significant correlation with HOMA 1IR (0.278, p = 0.01), but not with HOMA 1B (0.138, p = 0.257) in women. We found a correlation with HOMA 1B in men (r = 0.37, p = 0.044), but not with HOMA 1IR: 0.203, p = 0.283. The analysis performed based on body mass index did not show correlation in the patients with normal weight, (HOMA 1B r = 0.08, p = 0.5, HOMA 1IR = 0.034, p = 0.793), nor in the patients who were overweight (HOMA 1B: r = 0.05, p = 0.76, HOMA 1IR r = 0.145, p = 0.43). However, a significant correlation between uricemia with both HOMA 1B (0.559, p < 0.001), and HOMA 1IR (0.326, p < 0.05), was observed in obese patients. Our results suggest that serum uric acid levels seem to be associated with insulin resistance in women, and in obese patients, but not in nonobese men. Uric acid also modifies β-cell function in men and in obese patients.
- 11 October 2017
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 8 (10) , 141-146
Open AccessSerum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid
Hyperuricemia leads to insulin resistance, whereas insulin resistance decreases renal excretion of uric acid. The aim of this study was to evaluate whether there is a correlation between serum uric acid levels with homeostatic model assessment (HOMA) 1 in nondiabetic patients. We evaluated 88 nondiabetic patients, in whom uric acid levels were measured, in all of them HOMA of β-cell function (HOMA 1B) and HOMA of insulin resistance (HOMA 1IR) scores were performed. Uric acid and the HOMA 1 values were correlated using the Pearson coefficient. We did not find any correlation between uric acid levels with both HOMA 1B (r = 0.102, p = 0.343), nor with HOMA 1IR (r = 0.158, p = 0.117). When patients were analyzed by sex, we found a significant correlation with HOMA 1IR (0.278, p = 0.01), but not with HOMA 1B (0.138, p = 0.257) in women. We found a correlation with HOMA 1B in men (r = 0.37, p = 0.044), but not with HOMA 1IR: 0.203, p = 0.283. The analysis performed based on body mass index did not show correlation in the patients with normal weight, (HOMA 1B r = 0.08, p = 0.5, HOMA 1IR = 0.034, p = 0.793), nor in the patients who were overweight (HOMA 1B: r = 0.05, p = 0.76, HOMA 1IR r = 0.145, p = 0.43). However, a significant correlation between uricemia with both HOMA 1B (0.559, p < 0.001), and HOMA 1IR (0.326, p < 0.05), was observed in obese patients. Our results suggest that serum uric acid levels seem to be associated with insulin resistance in women, and in obese patients, but not in nonobese men. Uric acid also modifies β-cell function in men and in obese patients.